A detailed history of New York State Common Retirement Fund transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 36,033 shares of CPRX stock, worth $742,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,033
Previous 49,333 26.96%
Holding current value
$742,279
Previous $764,000 6.28%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$15.19 - $21.35 $202,027 - $283,955
-13,300 Reduced 26.96%
36,033 $716,000
Q2 2024

Jul 31, 2024

BUY
$14.68 - $16.92 $135,290 - $155,934
9,216 Added 22.97%
49,333 $764,000
Q1 2024

May 07, 2024

SELL
$13.18 - $17.11 $380,730 - $494,256
-28,887 Reduced 41.86%
40,117 $639,000
Q4 2023

Feb 01, 2024

SELL
$11.78 - $17.29 $37,436 - $54,947
-3,178 Reduced 4.4%
69,004 $1.16 Million
Q3 2023

Nov 07, 2023

BUY
$11.69 - $15.02 $374,383 - $481,030
32,026 Added 79.75%
72,182 $844,000
Q2 2023

Aug 07, 2023

SELL
$11.5 - $18.08 $125,074 - $196,638
-10,876 Reduced 21.31%
40,156 $540,000
Q1 2023

May 02, 2023

SELL
$14.34 - $21.05 $258,048 - $378,794
-17,995 Reduced 26.07%
51,032 $846,000
Q4 2022

Jan 30, 2023

BUY
$12.25 - $19.5 $98 - $156
8 Added 0.01%
69,027 $1.28 Million
Q3 2022

Nov 08, 2022

BUY
$7.06 - $15.52 $51,192 - $112,535
7,251 Added 11.74%
69,019 $886,000
Q2 2022

Aug 04, 2022

BUY
$6.23 - $8.57 $29,349 - $40,373
4,711 Added 8.26%
61,768 $433,000
Q1 2022

May 05, 2022

BUY
$5.31 - $8.31 $387 - $606
73 Added 0.13%
57,057 $473,000
Q4 2021

Feb 02, 2022

SELL
$5.21 - $7.45 $1,203 - $1,720
-231 Reduced 0.4%
56,984 $386,000
Q3 2021

Nov 02, 2021

SELL
$4.85 - $6.04 $96,262 - $119,881
-19,848 Reduced 25.76%
57,215 $303,000
Q2 2021

Aug 02, 2021

BUY
$4.29 - $6.05 $3,299 - $4,652
769 Added 1.01%
77,063 $443,000
Q1 2020

May 06, 2020

SELL
$2.61 - $5.21 $219,179 - $437,520
-83,977 Reduced 52.4%
76,294 $294,000
Q4 2019

Feb 05, 2020

BUY
$3.67 - $5.7 $232,593 - $361,248
63,377 Added 65.41%
160,271 $601,000
Q2 2019

Aug 09, 2019

BUY
$2.7 - $6.11 $55,890 - $126,477
20,700 Added 27.17%
96,894 $372,000
Q2 2018

Aug 10, 2018

BUY
$2.26 - $3.84 $2,711 - $4,608
1,200 Added 1.6%
76,194 $238,000
Q1 2018

May 10, 2018

BUY
$2.39 - $4.01 $57,838 - $97,042
24,200 Added 47.64%
74,994 $179,000
Q3 2017

Nov 06, 2017

BUY
$2.4 - $2.94 $22,545 - $27,618
9,394 Added 22.69%
50,794 $128,000
Q2 2017

Aug 11, 2017

BUY
N/A
41,400
41,400 $114,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.